Skip to main content

Diabetes I or II Sensor GENESIS

Status: Open to Enrollment
Email Us To Enroll

Locations

  • Burlingame

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

The study is a multi-center, prospective single-arm design without controls for adult and pediatric subjects with type 1 or type 2 diabetes. All subjects will be assigned to treatment for 7-17 days of sensor wear. Each subject will wear between 1 and 4 sensors, and each will be connected to/integrated with a transmitter. Subjects 2-12 years of age will wear up to 2 study glucose sensors, subjects 13 years and older will wear up to 4 study glucose sensors.

David Klonoff
David Klonoff
Principal investigator
View Profile

Email Us to Enroll

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?